Quabbin Clinical Research - Order Form (signed)
Documentexecuted Quabbin Clinical Research · order form · executed · 23 Mar 2026
Executed Enterprise order form under the MSA, 7 Apr 2026 to 6 Apr 2027. Availability 99.9%, P1 first response half an hour, annual subscription £119k after a 5% first-term discount. Total contract value £149k includes the £30k implementation.
What it says
What this says
As at Fri 9 Oct 2026Executed Enterprise order form under the MSA, 7 Apr 2026 to 6 Apr 2027. Availability 99.9%, P1 first response half an hour, annual subscription £119k after a 5% first-term discount. Total contract value £149k includes the £30k implementation.
What it is: an executed order form under the BG-Demo Master Services Agreement for Quabbin Clinical Research. It states that it "takes precedence over any earlier draft or quotation", so it sets contracted price and terms.
Commits: Enterprise service levels of 99.9% availability, P1 first response of half an hour, and nightly refresh "Complete by 07:00 customer local time on business days". The service credit is 10% of one month's fee for each month with a breach, on availability and data freshness. Fees are invoiced quarterly in advance, payable within 30 days.
Unusual: the 5% discount applies to the first term only, and at renewal the subscription is charged at the list price then in force. The £149k total includes the one-off fee and is not the annual price. The implementation line allows up to twelve connectors, with no delivery dates stated.
Not settled: the customer signatory is only named as an authorised signatory, so the evidence does not show who signed. No renewal notice period or auto-renewal wording is stated.
As found in this document
As at Fri 9 Oct 2026- Date end6 Apr 2027Source: the AI read of this record
- Date signed23 Mar 2026Source: the AI read of this record
- Date start7 Apr 2026Source: the AI read of this record
- Price£118,750Source: the AI read of this record
- Availability99.9%Source: the AI read of this record
- P1 first responseHalf an hourSource: the AI read of this record
- Nightly data refreshComplete by 07:00 customer local time on business daysSource: the AI read of this record
- Service credit10% of one month's fee for each month with a breachSource: the AI read of this record
- Credit basisAvailability and data freshnessSource: the AI read of this record
- Annual recurring subscription£118,750Source: the AI read of this record
- One-off implementation fee£30,000Source: the AI read of this record
- Total contract value£148,750Source: the AI read of this record
- BillingQuarterly in advance, each invoice payable within 30 daysSource: the AI read of this record
- Renewal pricingAt renewal the subscription is charged at the list price then in force, unless the parties agree otherwise in writingSource: the AI read of this record
The document
Body
Quabbin Clinical Research - Order Form (signed)
Status: Executed
This order form is made under the BG-Demo Master Services Agreement between the parties named below. It records the subscription and the implementation that Quabbin Clinical Research has bought, and it takes precedence over any earlier draft or quotation.
Parties
| Supplier | BG-Demo, London |
| Customer | Quabbin Clinical Research, Boston |
| BG-Demo account owner | Jordan Pike, Account Executive, US |
| BG-Demo customer success manager | Hollie Grieve |
Order details
| Order date | 23 Mar 2026 |
| Tier | Enterprise |
| Subscription start date | 7 Apr 2026 |
| Subscription end date | 6 Apr 2027 |
| Billing frequency | Quarterly |
| Payment terms | 30 days from invoice |
| Currency | GBP |
Order lines
Read the whole document (2,976 characters)
| SKU | Description | Qty | Unit price | Discount | Net amount | Recurring |
|---|---|---|---|---|---|---|
| SUB-ENTERPRISE | B-Viz Enterprise subscription (annual) | 1 | £125k | 5% | £119k | Yes |
| IMP-ENTERPRISE | Implementation, Enterprise: twelve weeks, security review support, up to twelve connectors | 1 | £30k | 0% | £30k | No, one-off |
Pricing summary
| Annual recurring subscription | £119k |
| One-off implementation fee | £30k |
| Total contract value | £149k |
The 5% discount applies to the first subscription term only. At renewal the subscription is charged at the list price then in force, unless the parties agree otherwise in writing.
The total contract value includes the one-off implementation fee. It is not the annual price. The annual price of the subscription is £119k.
Service levels
The following service levels apply to the Enterprise subscription for the term of this order form.
| Measure | Commitment |
|---|---|
| Availability | 99.9% |
| P1 first response | Half an hour |
| Nightly data refresh | Complete by 07:00 customer local time on business days |
| Service credit | 10% of one month's fee for each month with a breach |
| Credit basis | Availability and data freshness |
Term and billing
- The subscription runs from 7 Apr 2026 to 6 Apr 2027.
- Subscription fees are invoiced quarterly in advance, each invoice payable within 30 days.
- The implementation fee is a fixed fee for the scope described in the order lines. Changes to scope are agreed in writing before work starts.
- B-Viz is built and run inside the customer's own Snowflake account.
General
All other terms are those of the Master Services Agreement. If this order form and the Master Services Agreement conflict on price, service levels or term, this order form prevails.
Signatures
| For BG-Demo | For Quabbin Clinical Research | |
|---|---|---|
| Name | Jordan Pike | Authorised signatory |
| Title | Account Executive, US | Authorised signatory for the customer |
| Date | 23 Mar 2026 | 23 Mar 2026 |
Unusual terms
As at Fri 9 Oct 2026- 5% first-term discount
- Implementation includes up to twelve connectors
- Total contract value includes one-off fee